Abstract: This disclosure details exemplary battery pack designs for use in electrified vehicles. Exemplary battery packs may include an enclosure assembly that houses one or more battery arrays. The battery arrays may be efficiently arranged relative to one another inside the enclosure assembly to establish an open channel within the enclosure assembly. Coolant lines and/or wiring lines may be positioned within and/or routed through the open channel in order to maximize battery internal component volume without increasing the overall footprint of the enclosure assembly.

Abstract: This disclosure details exemplary battery pack designs for use in electrified vehicles. Exemplary battery packs may include an enclosure assembly that houses one or more battery arrays. The battery arrays may be efficiently arranged relative to one another inside the enclosure assembly to establish an open channel within the enclosure assembly. Coolant lines and/or wiring lines may be positioned within and/or routed through the open channel in order to maximize battery internal component volume without increasing the overall footprint of the enclosure assembly.

Abstract: A traction battery pack assembly includes, among other things, an enclosure having a lid and a tray. The enclosure has a corner area connecting a first side of the enclosure to a second side of the enclosure. The first side is transverse to the second side. The assembly further includes a patch secured to the corner area.

Abstract: This disclosure details exemplary battery pack designs for use in electrified vehicles. Exemplary battery packs may include an enclosure assembly that houses one or more battery arrays. The battery arrays may be efficiently arranged relative to one another inside the enclosure assembly to establish an open channel within the enclosure assembly. Coolant lines and/or wiring lines may be positioned within and/or routed through the open channel in order to maximize battery internal component volume without increasing the overall footprint of the enclosure assembly.

Abstract: A coil rack carrier for guiding and carrying a plurality of coil racks includes a pair of upstanding front guide members laterally spaced apart from one another and a pair of upstanding rear guide members laterally spaced apart from one another. Each rear guide member defines a length that is greater than a length of each front guide member. One of the pair of rear guide members is rearwardly adjacent a first one of the front guide members so as to define a first channel therebetween. Similarly, another of the pair of rear guide members is rearwardly adjacent a second one of the front guide members so as to define a second channel therebetween. For stowage the plurality of coil racks is sequentially received into the first and second channels.

Abstract: A device (250) for estimating the risk of a future hypoglycemic event for a subject with a standing insulin regimen (206), wherein the standing insulin regimen comprises one or more types of insulin medicament dosage regimen (208), wherein each of the one or more types of insulin medicament dosage regimen (208) comprises a type of insulin medicament (210) defining one or more types of insulin medicaments. Using the evaluation of a glucose concentration, a first time derivative and an insulin on board for the subject in a current metabolic state, and the evaluation of a glucose concentration, a first derivative and a historical insulin on board to estimate a hypoglycemic risk measure.

Abstract: Systems and methods for treating a subject are provided. A first dataset comprising timestamped autonomous glucose measurements of the subject over a first time course is obtained. A second dataset, associated with a standing insulin regimen for the subject over the first time course and comprising insulin medicament records, is also obtained. Each record comprises a timestamped injection event including an amount and type of insulin medicament injected into the subject by an insulin pen. The first and second datasets serve to calculate a glycaemic risk measure and an insulin sensitivity factor of the subject during the first time course, which are used to obtain a basal titration schedule and a fasting blood glucose profile model over a subsequent second time course for the subject. The model predicts the fasting blood glucose level of the subject based upon amounts of basal insulin medicament injected into the subject.

Abstract: The invention relates to an administration regimen useful in the treatment of diseases or conditions where administration of insulin will be of benefit. In particular, the invention relates to a long-acting or ultra-long acting insulin for use in treating a disease or condition where administration of insulin will be of benefit, wherein the administration of said insulin includes or consists of one or more of the following steps: (a) obtaining a first data set of the subject, (b) obtaining a second data set of the subject, (c) obtaining a first data structure of the subject, and (d) obtaining a second data structure of the subject. When a determination is made that the at least first data structure, second data structure, first data set, and second data set collectively do contain the set of evaluation information, the method further includes providing the long-acting or ultra-long-acting insulin dose guidance recommendation.

Abstract: This disclosure details exemplary electrical architectural layouts for distributing high voltage power within electrified vehicles. An exemplary battery pack associated with an electrical architectural layout of an electrified vehicle may include an enclosure assembly that houses one or more battery arrays. The battery arrays may be efficiently arranged relative to one another inside the enclosure assembly to establish an open channel within the enclosure assembly. A high voltage wiring harness may be routed through an interior of the battery pack within the open channel. The exemplary electrical architectural layouts of this disclosure may be employed within all-wheel drive, rear-wheel drive, or front-wheel drive electrified vehicles.

Abstract: Systems and methods for treating a subject are provided. A first dataset comprising timestamped autonomous glucose measurements of the subject over a first time course is obtained. A second dataset, associated with a standing insulin regimen for the subject over the first time course and comprising insulin medicament records, is also obtained. Each record comprises a timestamped administration event including an amount and type of insulin medicament administered into the subject by an insulin delivery device. The first and second datasets serve to calculate a glycemic risk measure and an insulin sensitivity factor of the subject during the first time course, which are used to obtain a basal rate titration schedule and a fasting blood glucose profile model over a subsequent second time course for the subject. The model predicts the fasting blood glucose level of the subject based upon amounts of insulin medicament administered into the subject.

Abstract: This disclosure details exemplary battery pack designs for use in electrified vehicles. An exemplary battery pack may include an enclosure assembly that houses one or more battery arrays. An impact protection shroud is mounted to a portion of at least one of the battery arrays. A battery sensitive component is at least partially covered by the impact protection shroud. The impact protection shroud is configured to establish minimum clearances relative the battery sensitive component and to redirect loads away from the battery sensitive component, thereby protecting the battery sensitive component during vehicle impact loading events.

Abstract: This disclosure details exemplary battery pack designs for use in electrified vehicles. Exemplary battery packs may include an enclosure assembly that houses one or more battery arrays. The battery arrays may be efficiently arranged relative to one another inside the enclosure assembly to establish an open channel within the enclosure assembly. Coolant lines and/or wiring lines may be positioned within and/or routed through the open channel in order to maximize battery internal component volume without increasing the overall footprint of the enclosure assembly.

Abstract: This disclosure details exemplary electrical architectural layouts for distributing high voltage power within electrified vehicles. An exemplary battery pack associated with an electrical architectural layout of an electrified vehicle may include an enclosure assembly that houses one or more battery arrays. The battery arrays may be efficiently arranged relative to one another inside the enclosure assembly to establish an open channel within the enclosure assembly. A high voltage wiring harness may be routed through an interior of the battery pack within the open channel. The exemplary electrical architectural layouts of this disclosure may be employed within all-wheel drive, rear-wheel drive, or front-wheel drive electrified vehicles.

Abstract: This disclosure details mounting systems and associated methods for mounting a battery pack to an electrified vehicle. An exemplary electrified vehicle may include a frame, a battery pack, and a mounting system for mounting the battery pack to the frame. The mounting system may include one or more side rails. Each side rail may include a predefined crush initiator configured to plastically deform for absorbing and transferring energy during vehicle impact loading events.

Abstract: This disclosure details mounting systems and associated methods for mounting a battery pack to an electrified vehicle. An exemplary electrified vehicle may include a frame, a battery pack, and a mounting system for mounting the battery pack to the frame. The mounting system may include one or more side rails. Each side rail may include a predefined crush initiator configured to plastically deform for absorbing and transferring energy during vehicle impact loading events.

Abstract: The present invention is a gate latching system for use in securing a pair of cooperating stock gates together. A preferred embodiment of the invention employs a pair of latching devices for securing a pair of overlapping stock gates together in a closed position. An alternate embodiment of the invention is designed with an extended arm for securing a pair of stock gates closed when the stock gates do not overlap. Both pairs of latching devices are designed so that one of the latching devices is bolted to one gate and the other latching device is bolted to the other gate. Each latching device has a u-shaped receiver for receiving a horizontal member of the opposite gate. The horizontal members enter the u-shaped receivers by lifting one of the gates as the gates are being closed and are secure therein by a lid that closes over one receiver.

Abstract: The invention relates to a novel administration regime useful in the treatment of diseases or conditions where administration of insulin will be of benefit. In particular, the invention relates to a long-acting or ultra-long acting insulin for use in treating a disease or condition where administration of insulin will be of benefit, wherein the administration of said insulin includes or consists of one or more of the following steps: (a) obtaining a first data set of the subject, (b) obtaining a second data set of the subject, (c) obtaining a first data structure of the subject, and (d) obtaining a second data structure of the subject. When a determination is made that the at least first data structure, second data structure, first data set, and second data set collectively do contain the set of evaluation information, the device further includes providing the long-acting or ultra-long-acting insulin dose guidance recommendation.

Abstract: Systems and methods for treating a subject are provided. A first dataset comprising timestamped autonomous glucose measurements of the subject over a first time course is obtained. A second dataset, associated with a standing insulin regimen for the subject over the first time course and comprising insulin medicament records, is also obtained. Each record comprises a timestamped administration event including an amount and type of insulin medicament administered into the subject by an insulin delivery device. The first and second datasets serve to calculate a glycaemic risk measure and an insulin sensitivity factor of the subject during the first time course, which are used to obtain a basal rate titration schedule and a fasting blood glucose profile model over a subsequent second time course for the subject. The model predicts the fasting blood glucose level of the subject based upon amounts of insulin medicament administered into the subject.

Abstract: A device (250) for estimating the risk of a future hypoglycemic event for a subject with a standing insulin regimen (206), wherein the standing insulin regimen comprises one or more types of insulin medicament dosage regimen (208), wherein each of the one or more types of insulin medicament dosage regimen (208) comprises a type of insulin medicament (210) defining one or more types of insulin medicaments. Using the evaluation of a glucose concentration, a first time derivative and an insulin on board for the subject in a current metabolic state, and the evaluation of a glucose concentration, a first derivative and a historical insulin on board to estimate a hypoglycemic risk measure.

Abstract: A trailer hitch stinger assembly for a towing vehicle, wherein the tow vehicle has a frame, a stinger and a trailer hitch, comprising: a trailer hitch stinger having a hitch, and a retainer wherein the retainer is slidably mounted around the trailer hitch stinger and further comprises a central slot is adapted to engage the trailer hitch stinger, a right slot adapted to receive a first chain from a trailer, and a left slot adapted to receive a second chain from the trailer.